These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Affordability Boards - The States' New Fix for Drug Pricing. Sklar T; Robertson C N Engl J Med; 2019 Oct; 381(14):1301-1303. PubMed ID: 31577871 [No Abstract] [Full Text] [Related]
8. Pharmaceuticals issue brief: pharmaceuticals cost control: year end report--2004. Seay M Issue Brief Health Policy Track Serv; 2004 Dec; ():1-17. PubMed ID: 15724308 [No Abstract] [Full Text] [Related]
9. Gift giving. Raszkowski RR S D J Med; 2002 Dec; 55(12):513-4. PubMed ID: 12516357 [No Abstract] [Full Text] [Related]
10. Medicare and drug pricing. Iglehart JK N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381 [No Abstract] [Full Text] [Related]
11. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
12. Lower Prices and Greater Patient Access - Lessons from Germany's Drug-Purchasing Structure. Robinson JC N Engl J Med; 2020 Jun; 382(23):2177-2179. PubMed ID: 32492300 [No Abstract] [Full Text] [Related]
13. The States as Important Laboratories for Federal Prescription Drug Cost-Containment Efforts. Horvath JC; Anderson GF JAMA; 2019 Apr; 321(16):1561-1562. PubMed ID: 31012941 [No Abstract] [Full Text] [Related]
14. Opinion: price controls on prescription drugs. Franks B N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791 [No Abstract] [Full Text] [Related]
15. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: business practices. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448 [No Abstract] [Full Text] [Related]
17. Pharmaceuticals and medical devices: business practices. End-of-year issue brief. Jones TM Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554 [No Abstract] [Full Text] [Related]
18. Increase competition to stabilize drug prices. Miller HI Science; 2001 Jul; 293(5528):213-4. PubMed ID: 11452976 [No Abstract] [Full Text] [Related]
19. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555 [No Abstract] [Full Text] [Related]
20. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs. Gudiksen KL; King JS J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534 [No Abstract] [Full Text] [Related] [Next] [New Search]